Complete Genome Sequence of Bacillus toyonensis Strain HA0190, Isolated from a Commercial Hydroxyapatite Product Extensively Used as a Synthetic Bone Graft Substitute.

Sung Guk Kim Miseon Park Christine V Summage-West Seonggi Min Steven L Foley

Microbiol Resour Announc

Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.

Published: April 2022

Bacillus toyonensis is a member of the Bacillus cereus group and is used as a probiotic in animal feeds and biological applications. We report the 5.8-Mbp genome sequence of strain HA0190, an isolate from a commercial hydroxyapatite nanoparticle product. The genome contains a circular chromosome and two plasmids, pBT001 and pBT002.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022546	PMC
http://dx.doi.org/10.1128/mra.00105-22	DOI Listing

Publication Analysis

Top Keywords

genome sequence

bacillus toyonensis

strain ha0190

commercial hydroxyapatite

complete genome

sequence bacillus

toyonensis strain

ha0190 isolated

isolated commercial

hydroxyapatite product

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!